ML Yates, EL Barker - Molecular pharmacology, 2009 - ASPET
The cannabinoid field is currently an active research area. Anandamide (AEA) and 2- arachidonoylglycerol (2-AG) are the most characterized endogenous cannabinoids (also …
A Luchicchi, M Pistis - Molecular neurobiology, 2012 - Springer
Since the discovery of endocannabinoids and their receptors, two major members of the endocannabinoid family, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), have been …
Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2. Endocannabinoid signaling is terminated by …
Endocannabinoids are a new class of lipid mediators, which includes amides and esters of long-chain polyunsaturated fatty acids. Anandamide (I) and 2-arachidonoylglycerol (II) are …
BF Cravatt, AH Lichtman - Current opinion in chemical biology, 2003 - Elsevier
The medicinal properties of exogenous cannabinoids have been recognized for centuries and can largely be attributed to the activation in the nervous system of a single G-protein …
GG Muccioli - Drug discovery today, 2010 - Elsevier
Cannabinoid receptors, the primary molecular targets of the endocannabinoid system, are activated by specific bioactive lipids termed 'endocannabinoids'. These lipid transmitters are …
Why endocannabinoids are not all alike | Nature Neuroscience Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To …
RA Puffenbarger - Current Drug Targets-CNS & Neurological …, 2005 - ingentaconnect.com
Endocannabinoid circuits have been shown to regulate a number of important pathways including pain, feeding, memory and motor coordination. Direct manipulation of …